Swiss-Prot entry

ID   KCMB2_MOUSE    STANDARD;      PRT;   235 AA.
AC   Q9CZM9;
DT   05-JUL-2004 (Rel. 44, Created)
DT   05-JUL-2004 (Rel. 44, Last sequence update)
DT   13-SEP-2005 (Rel. 48, Last annotation update)
DE   Calcium-activated potassium channel beta subunit 2 (Calcium-activated
DE   potassium channel, subfamily M, beta subunit 2) (Maxi K channel beta
DE   subunit 2) (BK channel beta subunit 2) (Slo-beta 2) (K(VCA)beta 2)
DE   (Charybdotoxin receptor beta subunit 2) (BKbeta2).
GN   Name=Kcnmb2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; 
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; 
OC   Muridae; Murinae; Mus. 
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=C57BL/6; TISSUE=Kidney;
RA   Garcia-Valdes J., Eghbali M., Stefani E., Toro L.;
RT   "Mouse kcnmb2 subunit of the large conductance calcium-activated K
RT   channel (MaxiK, BK).";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   MEDLINE=22354683; PubMed=12466851 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1038/nature01266;
RA   Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S.,
RA   Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H.,
RA   Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T.,
RA   Baldarelli R., Hill D.P., Bult C., Hume D.A., Quackenbush J.,
RA   Schriml L.M., Kanapin A., Matsuda H., Batalov S., Beisel K.W.,
RA   Blake J.A., Bradt D., Brusic V., Chothia C., Corbani L.E., Cousins S.,
RA   Dalla E., Dragani T.A., Fletcher C.F., Forrest A., Frazer K.S.,
RA   Gaasterland T., Gariboldi M., Gissi C., Godzik A., Gough J.,
RA   Grimmond S., Gustincich S., Hirokawa N., Jackson I.J., Jarvis E.D.,
RA   Kanai A., Kawaji H., Kawasawa Y., Kedzierski R.M., King B.L.,
RA   Konagaya A., Kurochkin I.V., Lee Y., Lenhard B., Lyons P.A.,
RA   Maglott D.R., Maltais L., Marchionni L., McKenzie L., Miki H.,
RA   Nagashima T., Numata K., Okido T., Pavan W.J., Pertea G., Pesole G.,
RA   Petrovsky N., Pillai R., Pontius J.U., Qi D., Ramachandran S.,
RA   Ravasi T., Reed J.C., Reed D.J., Reid J., Ring B.Z., Ringwald M.,
RA   Sandelin A., Schneider C., Semple C.A., Setou M., Shimada K.,
RA   Sultana R., Takenaka Y., Taylor M.S., Teasdale R.D., Tomita M.,
RA   Verardo R., Wagner L., Wahlestedt C., Wang Y., Watanabe Y., Wells C.,
RA   Wilming L.G., Wynshaw-Boris A., Yanagisawa M., Yang I., Yang L.,
RA   Yuan Z., Zavolan M., Zhu Y., Zimmer A., Carninci P., Hayatsu N.,
RA   Hirozane-Kishikawa T., Konno H., Nakamura M., Sakazume N., Sato K.,
RA   Shiraki T., Waki K., Kawai J., Aizawa K., Arakawa T., Fukuda S.,
RA   Hara A., Hashizume W., Imotani K., Ishii Y., Itoh M., Kagawa I.,
RA   Miyazaki A., Sakai K., Sasaki D., Shibata K., Shinagawa A.,
RA   Yasunishi A., Yoshino M., Waterston R., Lander E.S., Rogers J.,
RA   Birney E., Hayashizaki Y.;
RT   "Analysis of the mouse transcriptome based on functional annotation of
RT   60,770 full-length cDNAs.";
RL   Nature 420:563-573(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6; TISSUE=Brain;
RX   MEDLINE=22388257; PubMed=12477932 [NCBI, ExPASy, EBI, Israel, Japan]; DOI=10.1073/pnas.242603899;
RA   Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G.,
RA   Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D.,
RA   Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K.,
RA   Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F.,
RA   Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L.,
RA   Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E.,
RA   Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C.,
RA   Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J.,
RA   Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H.,
RA   Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W.,
RA   Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A.,
RA   Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A.,
RA   Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G.,
RA   Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C.,
RA   Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M.,
RA   Butterfield Y.S.N., Krzywinski M.I., Skalska U., Smailus D.E.,
RA   Schnerch A., Schein J.E., Jones S.J.M., Marra M.A.;
RT   "Generation and initial analysis of more than 15,000 full-length human
RT   and mouse cDNA sequences.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16899-16903(2002).
CC   -!- FUNCTION: Regulatory subunit of the calcium activated potassium
CC       KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and
CC       gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel
CC       diversity. Acts as a negative regulator that confers rapid and
CC       complete inactivation of KCNMA1 channel complex (By similarity).
CC   -!- SUBUNIT: Interacts with KCNMA1 tetramer. There are probably 4
CC       molecules of KCMNB2 per KCNMA1 tetramer (By similarity).
CC   -!- SUBCELLULAR LOCATION: Integral membrane protein (By similarity).
CC   -!- DOMAIN: The ball and chain domain mediates the inactivation of
CC       KCNMA1. It occludes the conduction pathway of KCNMA1 channels, and
CC       comprises the pore-blocking ball domain (residues 1-17) and the
CC       chain domain (residues 20-45) linking it to the transmembrane
CC       segment. The ball domain is made up of a flexible N-terminus
CC       anchored at a well ordered loop-helix motif. The chain domain
CC       consists of a 4-turn helix with an unfolded linker at its C-
CC       terminus (By similarity).
CC   -!- PTM: N-glycosylated (By similarity).
CC   -!- SIMILARITY: Belongs to the KCNMB family.
CC   --------------------------------------------------------------------------
CC   This Swiss-Prot entry is copyright. It is produced through a collaboration
CC   between  the Swiss Institute of Bioinformatics  and the  EMBL outstation -
CC   the European Bioinformatics Institute.  There are no  restrictions on  its
CC   use as long as its content is in no way modified and this statement is not
CC   removed.
CC   --------------------------------------------------------------------------
DR   EMBL; AY062429; AAL38982.1; -; mRNA. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; AK012400; BAB28216.1; -; mRNA. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; BC046227; AAH46227.1; -; mRNA. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   EMBL; BC058957; AAH58957.1; -; mRNA. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR   HSSP; Q9Y691; 1JO6. [HSSP ENTRY / SWISS-3DIMAGE / PDB]
DR   SMR; Q9CZM9; 1-45.
DR   Ensembl; ENSMUSG00000037610; Mus_musculus
DR   MGI; MGI:1919663; Kcnmb2.
DR   InterPro; IPR003930; BK_channel_beta.
DR   InterPro; Graphical view of domain structure.
DR   PANTHER; PTHR10258; BK_channel_beta; 1.
DR   Pfam; PF03185; CaKB; 1.
DR   Pfam; Graphical view of domain structure.
DR   PRINTS; PR01450; BKCHANNELB.
DR   CMR; Q9CZM9.
DR   ProDom [Domain structure / List of seq. sharing at least 1 domain]
DR   HOVERGEN [Family / Alignment / Tree]
DR   BLOCKS; Q9CZM9.
DR   ProtoNet; Q9CZM9.
DR   ProtoMap; Q9CZM9.
DR   PRESAGE; Q9CZM9.
DR   DIP; Q9CZM9.
DR   ModBase; Q9CZM9.
DR   SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW   Glycoprotein; Ion transport; Ionic channel; Transmembrane; Transport.
FT   TOPO_DOM      1     46       Cytoplasmic (Potential).
FT   TRANSMEM     47     67       1 (Potential).
FT   TOPO_DOM     68    194       Extracellular (Potential).
FT   TRANSMEM    195    215       2 (Potential).
FT   TOPO_DOM    216    235       Cytoplasmic (Potential).
FT   REGION        1     45       Ball and chain.
FT   CARBOHYD     88     88       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD     96     96       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    119    119       N-linked (GlcNAc...) (Potential).
SQ   SEQUENCE   235 AA;  27120 MW;  F87D3D91C22BBDF2 CRC64;
     MFIWTSGRTS SSYRQDEKRN IYQKIRDHDL LDKRKTVTAL KAGEDRAILL GLAMMVCSIM
     MYFLLGITLL RSYMQSVWTE EAQCALLNVS ITETFNCSFS CGPDCWKLSQ YPCLQVYVNL
     TSSGERLLLY HTEETMKINQ KCSYIPKCGN NFEESMSLVS VVMENFRRHQ HFPCYSDPEG
     NQKSVILTKL YSSNVLFHSL FWPTCMMAGG VAIVAMVKLT QYLSLLCERI QRINR
//